| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/24/2004 | EP1478389A1 Treatment for diseases of the eye, inner ear and central nervous system |
| 11/24/2004 | EP1478388A1 Purification of red blood cells by separation and diafiltration |
| 11/24/2004 | EP1478387A1 Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences |
| 11/24/2004 | EP1478385A2 Bmp inhibitors for the treatment of spondyloarthropathies |
| 11/24/2004 | EP1478384A2 Method for increasing the survival of dopamine secreting cells |
| 11/24/2004 | EP1478383A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 11/24/2004 | EP1478382A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096 |
| 11/24/2004 | EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function |
| 11/24/2004 | EP1478378A2 Anti-allergic complex molecules |
| 11/24/2004 | EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 11/24/2004 | EP1478362A1 A combination treatment for acute myocardial infarction |
| 11/24/2004 | EP1478355A2 Antitumor compositions containing taxane derivatives |
| 11/24/2004 | EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection |
| 11/24/2004 | EP1478353A1 Sustained release pharmaceutical composition |
| 11/24/2004 | EP1478343A2 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment |
| 11/24/2004 | EP1478331A1 Method of stimulation of melanin production and induction of skin tanning |
| 11/24/2004 | EP1478328A2 Bioactive keratin peptides |
| 11/24/2004 | EP1478276A2 Novel targeted compositions for diagnostic and therapeutic use |
| 11/24/2004 | EP1478236A2 Targeted retrograde gene delivery to motor neurons |
| 11/24/2004 | EP1478233A2 Method for administering glp-1 molecules |
| 11/24/2004 | EP1285000B1 Adnf mixtures for enhancing learning and memory |
| 11/24/2004 | EP1257288B1 Use of il-9 for the treatment of gram negative bacteria infection |
| 11/24/2004 | EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 11/24/2004 | EP1200470B1 Globular assembly of amyloid beta protein and uses thereof |
| 11/24/2004 | EP1115452B1 System for treating ischemia |
| 11/24/2004 | EP1109572A4 Neuroprotection |
| 11/24/2004 | EP1109550B1 Novel nitrophenylaziridine compounds and their use as prodrugs |
| 11/24/2004 | EP1105155B1 Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 11/24/2004 | EP1079805B1 Pharmaceutical composition comprising factor viii and neutral liposomes |
| 11/24/2004 | EP1049787B1 Multipurpose antibody derivatives |
| 11/24/2004 | EP1027014B1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 11/24/2004 | EP1007677B1 Protease-related protein |
| 11/24/2004 | EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 11/24/2004 | EP0946185B1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 11/24/2004 | EP0914333B1 Peptide derivatives |
| 11/24/2004 | EP0912157B1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 11/24/2004 | EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 11/24/2004 | EP0883684B1 Method of purifying thrombin-like protease enzymes obtained from snake venom |
| 11/24/2004 | EP0856157B1 Tumour-specific p450 protein |
| 11/24/2004 | EP0830140B1 A pluripotent vaccine against enveloped viruses |
| 11/24/2004 | EP0826064B1 Low oxygen affinity mutant hemoglobin |
| 11/24/2004 | EP0783317B1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 11/24/2004 | EP0717752B1 Therapeutic compounds |
| 11/24/2004 | EP0656012B1 T cell epitopes of ryegrass pollen allergen |
| 11/24/2004 | CN1549862A Transgenic plants expressing cobalamin binding proteins |
| 11/24/2004 | CN1549826A Compositions and methods of treating diabetes |
| 11/24/2004 | CN1549824A Peptidic compounds selectively binding to p-selectin |
| 11/24/2004 | CN1549823A Production of high molecular mass lectins |
| 11/24/2004 | CN1549734A Aromatase inhibition to enhance assisted reproduction |
| 11/24/2004 | CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 11/24/2004 | CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 11/24/2004 | CN1549725A Hepatitis B virus proliferation inhibitor |
| 11/24/2004 | CN1549724A Methods of treating liver fibrosis |
| 11/24/2004 | CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity. |
| 11/24/2004 | CN1549722A Anti-cancer and wound healing compounds |
| 11/24/2004 | CN1548540A Polypeptide enzyme surface exhibiting technology and C-end polypeptide enzyme surface exhibition of cholesteryl ester transfer protein |
| 11/24/2004 | CN1548534A Reptilase and its production process and application |
| 11/24/2004 | CN1548530A Interaction and influence on proliferation of neure cell of BEX1, LMO2 and SNF5 |
| 11/24/2004 | CN1548459A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 11/24/2004 | CN1548458A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 11/24/2004 | CN1548457A Tumor antigen protein and tumor antigen peptide |
| 11/24/2004 | CN1548454A Tumor suppressor protein and its application |
| 11/24/2004 | CN1548452A One kind of membrane protein of SARS coronavirus and its encoding gene and application |
| 11/24/2004 | CN1548157A SARS resisting medicine action target and its preventing and treating medicine |
| 11/24/2004 | CN1548154A Pineapple proteinase microcapsule medicine composition for treating mammal diarrhea |
| 11/24/2004 | CN1548153A Application of enzymic hemostat in antagonizing hirudin hemorrhage |
| 11/24/2004 | CN1548152A Treating and preventing effect of lysozyme on SARS |
| 11/24/2004 | CN1548151A Combined biological medicine with active enzyme |
| 11/24/2004 | CN1548150A Sheep lamb increasing essence |
| 11/24/2004 | CN1548149A Application of recombinant alpha-interferon in preparing medicine for preventing and treating respiratory system infection |
| 11/24/2004 | CN1548148A Basic fibroblast growth factor recombining capsule and its prepn process |
| 11/24/2004 | CN1548147A Medicine composition for treating senile dementia |
| 11/24/2004 | CN1548054A Medicine for preventing and treatig SARS coronavirus |
| 11/24/2004 | CN1177051C Recombinant thymin alpha-1 and its prepn |
| 11/24/2004 | CN1177046C Enhanced virus-mediated DNA transfer |
| 11/24/2004 | CN1177042C Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application |
| 11/24/2004 | CN1176947C Parathyroid hormone analogues for the treatment of osteoporosis |
| 11/24/2004 | CN1176946C New-type alpha-interferon |
| 11/24/2004 | CN1176944C Antibacterial polypeptide separated from biological living body |
| 11/24/2004 | CN1176943C Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
| 11/24/2004 | CN1176942C Amino acid polypeptide with strong membrane-inserting capability |
| 11/24/2004 | CN1176941C Caspase inhibitors and the use thereof |
| 11/24/2004 | CN1176903C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindoprill |
| 11/24/2004 | CN1176719C Application for deplasmin in prepn. of internal hemostatic medicine |
| 11/24/2004 | CN1176718C Thymosin alpha-1 microball prepn and its prepn process |
| 11/24/2004 | CN1176717C Application of buthotoxin Bmk AS in preparing medicines |
| 11/24/2004 | CN1176716C Composition for prevention and/or treatment of atheromatous arteriosclerosis |
| 11/24/2004 | CN1176715C Water dispersive nano level bone morphogenetic protein injection prepn and its prepn process |
| 11/24/2004 | CN1176714C Method and composition for treating prostate cancer |
| 11/24/2004 | CN1176713C Application of serum beta 2-glucoprotein I as active component of thrombolytics |
| 11/24/2004 | CN1176697C Antisenility medicine composition and its prepn |
| 11/24/2004 | CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use |
| 11/23/2004 | US6822141 Diacylglycerol acyl transferase proteins |
| 11/23/2004 | US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition |
| 11/23/2004 | US6822083 TSA305 gene |
| 11/23/2004 | US6822080 For identification/cloning/drug screening; enzyme inhibitors |
| 11/23/2004 | US6822076 Hybrid ptorin for use in treating allergies and controlling immunogical response |
| 11/23/2004 | US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders |
| 11/23/2004 | US6822074 Comprises cyclization of precursor; for improved yield |
| 11/23/2004 | US6822070 Truncated CRAF1 inhibits CD40 signaling |